Name | Number of supported studies | Average coverage | |
---|---|---|---|
neutrophil | 3 studies | 19% ± 1% | |
GABAergic neuron | 3 studies | 28% ± 12% | |
glutamatergic neuron | 3 studies | 34% ± 15% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 22% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2848.90 | 1445 / 1445 | 100% | 24.98 | 183 / 183 |
skin | 100% | 2562.11 | 1809 / 1809 | 100% | 27.84 | 472 / 472 |
lung | 100% | 3215.79 | 578 / 578 | 100% | 34.54 | 1154 / 1155 |
thymus | 100% | 3335.67 | 653 / 653 | 100% | 28.62 | 604 / 605 |
prostate | 100% | 2554.36 | 245 / 245 | 100% | 26.16 | 501 / 502 |
uterus | 100% | 2507.81 | 170 / 170 | 100% | 34.93 | 458 / 459 |
intestine | 100% | 2641.81 | 966 / 966 | 100% | 19.47 | 525 / 527 |
breast | 100% | 3149.65 | 459 / 459 | 100% | 26.35 | 1113 / 1118 |
bladder | 100% | 2735.05 | 21 / 21 | 99% | 33.15 | 501 / 504 |
stomach | 100% | 1918.36 | 359 / 359 | 99% | 18.57 | 284 / 286 |
brain | 99% | 1960.58 | 2622 / 2642 | 100% | 15.70 | 705 / 705 |
liver | 100% | 1994.35 | 226 / 226 | 99% | 16.26 | 402 / 406 |
kidney | 100% | 1716.76 | 89 / 89 | 98% | 16.02 | 881 / 901 |
ovary | 100% | 1759.95 | 180 / 180 | 97% | 16.28 | 419 / 430 |
pancreas | 97% | 1038.56 | 319 / 328 | 99% | 22.57 | 176 / 178 |
adrenal gland | 100% | 1311.58 | 257 / 258 | 90% | 15.62 | 207 / 230 |
adipose | 100% | 3388.02 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 44.35 | 29 / 29 |
peripheral blood | 100% | 21097.44 | 929 / 929 | 0% | 0 | 0 / 0 |
spleen | 100% | 6917.60 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 39.82 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 52.70 | 1 / 1 |
blood vessel | 100% | 2015.95 | 1333 / 1335 | 0% | 0 | 0 / 0 |
heart | 100% | 1470.13 | 858 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 13.84 | 77 / 80 |
muscle | 91% | 912.35 | 731 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045824 | Biological process | negative regulation of innate immune response |
GO_0160049 | Biological process | negative regulation of cGAS/STING signaling pathway |
GO_0018345 | Biological process | protein palmitoylation |
GO_0018230 | Biological process | peptidyl-L-cysteine S-palmitoylation |
GO_0006612 | Biological process | protein targeting to membrane |
GO_0045087 | Biological process | innate immune response |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0016409 | Molecular function | palmitoyltransferase activity |
GO_0019706 | Molecular function | protein-cysteine S-palmitoyltransferase activity |
Gene name | ZDHHC18 |
Protein name | Zinc finger DHHC-type palmitoyltransferase 18 Palmitoyltransferase ZDHHC18 (EC 2.3.1.225) (DHHC domain-containing cysteine-rich protein 18) (DHHC-18) (Zinc finger DHHC domain-containing protein 18) Palmitoyltransferase (EC 2.3.1.225) |
Synonyms | |
Description | FUNCTION: Palmitoyltransferase that catalyzes the addition of palmitate onto various protein substrates, such as CGAS, HRAS and LCK . Acts as a negative regulator of the cGAS-STING pathway be mediating palmitoylation and inactivation of CGAS . May also have a palmitoyltransferase activity toward the beta-2 adrenergic receptor/ADRB2 and therefore regulate G protein-coupled receptor signaling . . |
Accessions | ENST00000488397.3 ENST00000374142.9 [Q9NUE0-1] H0YEN1 ENST00000534643.5 ENST00000374141.6 [Q9NUE0-2] E9PJS3 Q9NUE0 |